Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Home
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
$
30.00
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 4 Articles
Tags:
antipsychotic
,
deanna-l-kelly
,
medworks-media
,
pharmacodynamic
,
pharmacokinetic
,
psychopharmacology-bulletin
,
qtc-interval
,
raymond-c-love
,
torsades-de-pointes
,
ziprasidone
Description
Description
Deanna L. Kelly, PharmD, BCPP
DRUG INTERACTIONS
Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
Deanna L. Kelly, PharmD, BCPP, and Raymond C. Love, PharmD, BCPP, FASHP
Related products
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Test of Treatment in Psychiatric Practice by Feras Ali Mustafa
$
30.00
Add to cart
Details
Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology
$
30.00
Add to cart
Details
Page load link
Go to Top
